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Introduction
Lung cancer continues to be one of the major causes of 
cancer-related deaths in the world, and smoking is the 
primary cause of lung cancer1. Lung is a unique tissue 
for oxidant stress among most other organs because it is 
directly exposed to higher oxygen tensions. Because of 
their direct exposure to ambient air, lung cells experience 
enhanced oxidant stress by environmental irritants and 
pollutants including oxidants such as cigarette smoke, 
environmental carcinogens which generate free radicals2. 
Therefore, antioxidant enzyme activity and expression is 
very important for lung tissue.
The PTEN (phosphates and tensin homologue deleted 
on chromosome 10) tumour suppressor gene is frequently 
deleted or mutated in a wide variety of human cancers, 
including glioblastoma3, melanoma4, prostate cancer5, 
breast cancer6, lung cancer7, and endometrial cancer8. 
PTEN is also essential for embryonic development9,10. 
PTEN encodes a protein that has sequence homology with 
phosphatases which dephosphorylate both tyrosine and 
serine/threonin phosphates on proteins11–13. PTEN is also 
capable of dephosphorylating inositol phospholipids14. 
In particular, PTEN dephosphorylates phosphatidylinos-
itol-3,4,5-triphosphate (PIP3) and phosphatidylinositol-
4.5-biphosphate (PIP2). Therefore, PTEN can suppress 
AKT activity and inhibit the PI3K/AKT/NFκB pathway.
Nuclear factor kappa B (NF-κB) is a transcription 
factor regulating expression of multiple genes15, and 
has been shown to govern various cellular functions, 
including inflammatory and stress-induced responses 
and survival16. NF-κB activation is regulated by nega-
tive feedback mediated by IκB, an inhibitor protein that 
binds to NF-κB, but can undergo ubiquitination and 
proteasomal degradation17, thus freeing NF-κB to trans-
locate to the nucleus and initiate transcription18. NF-κB 
is a redox-sensitive transcription factor19, that has been 
proposed to be the sensor for oxidative stress20. It has also 
been reported that NFκB activity down-regulate Catalase 
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and SOD activity21. Therefore, we designed this study to 
investigate the suppressive effect of PTEN tumour sup-
pressor gene on intracellular oxidative stress in NSCLC 
cell lines.
Materials and methods
Cell culture
PC3, PC9 and PC14 cells were cultured in RPMI1640 
(Sigma-Aldrich, St. Louis, MO) supplemented with 10% 
fetal bovine serum (Invitrogen, Carlsbad, CA) and incu-
bated at 37°C in humidified incubator with 5% CO
2
.
Expression plasmids and transfections
PTENwt, lipidfosfatase dead PTEN G129E and kinase 
dead PTEN G129R were cloned in both, pcDNA3 and 
pcDNA6/TK expression vectors as described in our pre-
vious work22. By using FUGEN (Roche, Indianapolis, IN), 
PC14 cells were first stably transfected with regulatory 
plasmid pcDNA6/TK, and clones were selected by blas-
ticidin (10 µg/ml). Selected clones were then transfected 
with pcDNA4/TO-PTENwt, pcDNA4/TO-PTENG129R, 
and pcDNA4/TO-PTENG129E expression vectors. 
Double transfectants were selected in medium contain-
ing blasticidin (10 µg/ml) and zeocin (50 µg/ml), then 
stable transfected cells were treated 2 µg/ml tetracycline 
for 24 h to induce PTEN expression on these cells. PC9 
and PC3 cells were transiently transfected with pcDNA-
PTENwt, pcDNA-PTENG129R and pcDNA-PTENG129E, 
the expressions verified by western blotting.
Lysate preparation and western blot
Cells were grown to 80% confluency, washed with 
phosphate buffered saline, and incubated in serum free 
medium containing tetracyclin (2 µg/ml) for 24 h. Cell 
lysates were prepared in ice-cold RIPA buffer (10 mM 
Tris-HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% NP-40, 
1% sodiumdeoxycholate, 0.1% SDS). Cellular debri was 
removed by centrifugation at 12,000g for 5 min at 4°C. 
One hundred micrograms of proteins were subjected 
to SDS-PAGE using 2–15% or 7.5% poly-acrylamide gels 
(Pierce, Rockford, IL) at pH 7.0, proteins were immu-
noblotted onto Hybond-PVDF membrane (Amersham-
Pharmacia Biotech, Buckinghamshire, UK), and labeled 
with antibodies. AKT, phospho-AKT (Ser473), antibodies 
were obtained from Cell Signaling Technology (Beverly, 
MA). PTEN and horseradish peroxidase-conjugated 
secondary antibodies were obtained from Santa Cruz 
Biotechnology (Santa Cruz, CA). After primary and 
secondary antibody labeling blots were treated with 
Super Signal West Pico chemiluminescent substrate 
(Pierce), exposed to Hyperfilm ECL (Amersham-
PharmaciaBiotech) and developed.
Measurement of superoxide dismutase activity
Cell pellets were sonicated (Bandelin Sonopuls, 
Bandelin Electronic GmbH&Co., Berlin, Germany) in 
cold 20 mM HEPES buffer, pH 7.2, containing 1 mM 
EDTA (Sigma, Sigma-Aldrich Chemie, Steinheim, 
Germany). Cell homogenates were centrifuged at 
1,500g for 5 min at 4°C and supernatants were kept at 
−80°C until assayed. Superoxide activity was measured 
using a SOD activity assay kit (Cayman Chemical, Ann 
Arbor, MI) according to manufacturer’s instructions. 
The SOD activity assay kit utilizes a tetrazolium salt for 
detection of superoxide radicals generated by xanthine 
oxidase and hypoxanthine. One unit of SOD activity 
was defined as the amount of enzyme needed to exhibit 
50% dismutation of superoxide radical. The SOD assay 
measured both the cytosolic and mitochondrial activ-
ity of the enzyme.
Measurement of catalase activity
We measured catalase activity as described before23. 
Briefly, cell pellets were sonicated in cold 50 mM 
potassium phosphate, pH 7.0, containing 1 mM EDTA 
(Sigma, Sigma-Aldrich Chemie, Steinheim, Germany). 
Cell homogenates were centrifuged at 10,000g for 
15 min at 4°C and supernatants were kept at −80°C 
until assayed. Catalase activity was measured using a 
CAT activity assay kit (Cayman Chemical, Ann Arbor, 
MI) according to manufacturer’s instructions. The CAT 
activity assay kit utilizes the peroxidatic function of 
CAT for determination of enzyme activity. The method 
is based on the reaction of the enzyme with methanol 
in the presence of H
2
O
2
. The formaldehyde produced, 
is measured spectrophotometrically with purpald 
(4-amino-3-hydrazino-5-marcapto-1,2,4-traizole) as 
the chromogen. The formaldehyde produced by each 
sample was calculated from a standard curve obtained 
via the supplied standard within the kit. One unit of 
enzyme activity was defined as the amount of enzyme 
that caused the formation of 1 μmol formaldehyde per 
minute at 25°C.
Measurement of glutathione peroxidase activity
We measured glutathione peroxidase activity as 
described before23. Briefly, cell pellets were soni-
cated in cold 50 mM Tris-HCl (SERVA, Heidelberg, 
Germany) buffer at pH 7.5, containing 1 mM EDTA 
Figure 1. Western blot analysis of stably transfected PC14 
cells. Figure represent the stable expression of Mock, PTENwt, 
PTENG129E and PTENG129R and the effect of these expressions 
on AKT activity in NSCLC PC14 cell lines.
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(Sigma, Sigma-Aldrich Chemie, Steinheim, Germany). 
Cell homogenates were centrifuged at 10,000g for 
15 min at 4°C and supernatants were kept at −80°C 
until assayed. Glutathione peroxidase was measured 
using a GPx activity assay kit (Cayman Chemical, Ann 
Arbor, MI) according to manufacturer’s instructions. 
The GPx activity assay kit measures enzyme activ-
ity indirectly by a coupled reaction with glutathione 
reductase (GR). The oxidation of NADPH to NADP is 
accompanied by as decrease in absorbance at 340 nm. 
Absorbance kinetics was assessed spectrophotometri-
cally at 340 nm by using the NADPH extinction coeffi-
cient of 0.00622 μM/cm. One unit of enzyme activity 
was defined as the amount of enzyme that caused the 
oxidation of 1 μmol NADPH to NADP per minute at 
25°C.
Results
To show the possible effects of recreated PTEN expression 
on antioxidant enzymes catalase, GPx and SOD activity, 
we use NSCLC PC14, PC9 and PC3 cells which have no 
endogenous PTEN expression22,24. First, we transfected 
PC14 cells with pcDNA6-PTENwt, pcDNA6-PTENG129R 
and pcDNA6-PTENG129E and selected stably trans-
fected cells as described in the Materials and methods 
section. Stably transfected PTENwt, PTENG129R and 
PTENG129E expressing cells were lysed and PTEN 
expression was detected by western blot. In Figure 1, it 
is clearly shown that PTENwt, G129R and G129E expres-
sions were recreated in PC14 cells. PTEN wt expression 
leads to decreased p-AKT level. Lipid phosphatase dead 
(G129E) and kinase dead (G129R) PTEN expressions had 
no effect on p-AKT level, implicating that PTEN can sup-
press AKT activity by its lipid phosphatase ability.
It has previously been reported that SOD and 
catalase activity increase when NFκB activity is sup-
pressed21. Because PTEN suppresses PI3K/AKT/NFκB 
pathway and inhibits NFκB activity, we hypothesized 
that PTEN could also change the activity of antioxi-
dant enzymes by suppression of the PI3K/AKT/NFκB 
pathway. Therefore, we first examined recreated PTEN 
and its mutant effects on GPx, SOD and catalase activ-
ity in stable PTEN expressing PC14 cells. Interestingly, 
Figure 2. The effects of stable expression of Mock, PTENwt, 
PTENG129E and PTENG129R on catalase, GPx and SOD enzymes 
activity in NSCLC PC 14 cells.
Figure 3. Western blot analysis of transiently transfected PC9 and 
PC3 cells. Figure represents the transient expressions of Mock, 
PTENwt, PTENG129E and PTENG129R and the effect of these 
expressions on AKT activity in NSCLC PC9 and PC3 cell lines.
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our results indicate that, only PTENwt expression can 
induce the activity of GPx, SOD and catalase. Neither 
PTENG129R nor PTENG129E had an effect on these 
enzyme activities (Figure 2).
To understand whether the observed effects were 
cell specific or not, we transiently transfected PC9 
and PC3 cells with mock, PTENwt, PTENG129R and 
PTENG129E. These NSCLC cell lines, PC9 and PC3, 
have no endogenous PTEN expression22,24. We first 
transiently transfected PC9 and PC3 cells with mock, 
pcDNA3-PTENwt, pcDNA3-PTENG129R and pcDNA3-
PTENG129E. After 24 hours of transfection, cells were 
lysed for detection of PTEN expression and the effects 
of this expression on GPx, catalase, and SOD enzyme 
activities were analyzed. Figure 3 shows that stably 
transfected PC9 and PC3 cells start the expression of 
PTENwt, PTENG129R and PTENG129E. Only PTENwt 
expression reduced AKT activity. Lipid phosphatase 
dead PTENG129R and kinase dead PTENG129E could 
not change the activity of AKT, inferring that PTEN 
reduced AKT activity by its lipid phosphatase domain. 
We examined the effects of PTENwt, G129R and G129E 
expression on GPx, catalase and SOD enzyme activities 
in these transfected cells. In Figure 4, it is clearly shown 
that PTENwt can induce the activity of GPx, catalase 
and SOD. Lipid phosphatase dead PTENG129R and 
kinase dead PTENG129E could not change the activ-
ity of antioxidant enzymes, inferring that PTEN can 
induce antioxidant enzyme activity by suppression of 
PI3K/AKT pathway.
Figure 4. The effects of transient expressions of Mock, PTENwt, PTENG129E and PTENG129R on catalase, GPx and SOD enzymes activity 
in NSCLC PC 9 and PC3 cell lines.
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Discussion
In this study, we report that PTEN up-regulates cata-
lase, GPx and SOD activity with inhibition of PI3K/AKT 
pathway by its lipid dephosphorylase activity. Previously 
published data show that catalase enzyme activity can 
down-regulate PI3K/AKT signaling in mesangial cells. 
Venkatesan et  al.25 and Choi et  al.21 showed that when 
NFκB activity was suppressed with gemsitabin, SOD and 
catalase activity increase in macrophages. With reference 
to these data, we hypothesized that PTEN could possibly 
regulate antioxidant enzyme activity by inhibition of 
PI3K/AKT/NFκB pathway. We first transfected NSCLC 
cell line PC14 with mock, PTENwt, lipid phosphatase 
activity dead PTEN, G129E, and catalytically inactive 
PTEN, G129R. PTEN wt and 2 mutants of PTEN, G129E 
and G129R, were created and cloned before by our 
group22. As shown in Figure 1, PC14 cells have no detect-
able endogenous PTEN expression, and after transfec-
tion with PTENwt, G129E and G129R, expressions are 
recreated in these cells. Figure 1 clearly indicates that 
PTEN suppresses AKT with its lipid phosphatase activity 
inferring that PTEN inhibits PI3K/AKT pathway in PC14 
cells with its lipid phosphatase activity. We then exam-
ined the effect of PTENwt, G129E and G129R expression 
on GPx, catalase and SOD enzymes activity in PC14 
cells. Interestingly, only PTENwt expression induced the 
activity of GPx, catalase and SOD enzymes. G129E and 
G129R did not have an effect on antioxidant enzyme 
activities. Obtained data implicates that PTEN up-regu-
lates antioxidant enzyme activity via inhibition of PI3K/
AKT pathway by its lipid dephosphatase activity in PC14 
cells. These results are in good agreement with previous 
reports25,26. Venkatesan et  al.25 reported that PI3K/AKT 
pathway activation down-regulate catalase activity and 
Choi et  al.21 also showed that gemsitabin inhibition of 
NFκB activity leads to an increase in SOD and catalase 
activity. Moreover, Leung et  al.26 reported that antioxi-
dant enzyme activity was involved in apoptosis in human 
lung squamous carcinoma CH27 cells. These results are 
supported by our data. Knowing that PI3K/AKT/NFκB 
pathway works as a survival pathway in cells and that 
PTEN works as a tumour suppressor gene, it is so mean-
ingful that PTEN mediated inhibition of PI3K/AKT/NFκB 
pathway leads to up-regulation of antioxidant enzymes 
activity.
To understand whether the observed effects were 
cell specific or not, we transiently transfected PC9 
and PC3 cells with mock, PTENwt, PTENG129R and 
PTENG129E. These NSCLC cell lines, PC9 and PC3, 
have no endogenous PTEN expression22,24. In Figure 
3 it is clearly shown that PTENwt, G129E and G129R 
expressions are successfully recreated in PC9 and PC3 
cells. Then we examined these expressions effects on 
GPx, SOD and catalase enzymes activity. As seen in 
Figure 4, PTEN up-regulate catalase, SOD and GPx 
activity with its lipid phosphatase activity by inhibiting 
PI3K/AKT/NFκB pathway.
Conclusion
We clearly indicate in this study that tumour suppressor 
PTEN can enhance the activity of SOD, catalase and GPx 
enzymes activity through the inhibition of PI3K/AKT 
pathway.
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